Rapid progression of 'retinoic acid syndrome' in the hypogranular variant of acute promyelocytic leukaemia, despite treatment with dexamethasone and conventional chemotherapy.
Mahendra
P
P
Department of Haematology, Addenbrookes NHS Trust, Cambridge, UK.
Harman
K
K
Phillips
M
M
Gunning
K
K
Marcus
R E
RE
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000628:therapy; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000209:etiology; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D003907:Dexamethasone / Q000627:therapeutic use*; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications / Q000188:drug therapy*; D007964:Leukocytosis / Q000139:chemically induced*; D006435:Renal Dialysis; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000628:therapy; D013577:Syndrome; D014212:Tretinoin / Q000009:adverse effects*
D003561:Cytarabine; D014212:Tretinoin; D003907:Dexamethasone; D003630:Daunorubicin